Return to homepagePandemic Pact

Working towards controlled detection of SARS-CoV-2 by the innate immune system (CoV-2Sensing project)

  • Funded by Institut Pasteur International Network (IPIN)
  • Total publications:0 publications

Grant number: CoV-2Sensing

Grant search

Key facts

  • Disease

    COVID-19

  • Funder

    Institut Pasteur International Network (IPIN)

  • Principal Investigator

    N/A

  • Research Location

    France

  • Lead Research Institution

    N/A

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Immunity

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

Aim: controlling the SARS-CoV-2 outbreak requires both scientific knowledge and antiviral drugs. RIG-I-like receptors in the cell cytoplasm play a major role in detecting infection with RNA viruses and in initiating and modulating antiviral immunity. The aim of the project is to study the RNA ligands in the SARS-CoV-2 virus that are detected by these receptors. The project will shed light on the innate immune response to SARS-CoV-2, including the harmful effects of the immune response, thereby helping identify strategies for the design of broad-spectrum antiviral drugs and vaccine adjuvants.